NR2F1 and cancer: Further co-expression pattern analyses demonstrated highly consistent co-expression (P < 0.0001) of NR2F1-AS1 and NR2F1 across nine of the cancer types examined [with the exception of COAD due to the limited tumor sample number (18) used for calculations] (Figure 5D).